Skip to content

EMULCO LABORATORIES

Active
Private limited companyfounded 200521 yrs activeHenri Farmanstraat 25, 9000 Gent, BelgiumKBO/BCE: BE 0874.567.440
Summary

EMULCO LABORATORIES has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-119k) and a net result of €-320k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 10% of 8001 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Checked score

Score 2025
30 / 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability3▲+3
Solvency20▼-16
Growth58=
Track record100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.08 against 0.03 in 2024; short-term debt: 104.8% and cash: 0.7% of total assets), and equity is negative.
Credit check for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 21 years 0 30 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-4.8%
Return on assets
-13%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €-119k
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-08-2026, 25 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
25 d late
2024
29 d late
2023
29 d late
2022
31 d early
2021
16 d early
2020
9 d early
2019
52 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€-119k
2024 · €273k
2018: €1.23M 2019: €827k 2020: €411k 2021: €-56k 2022: €-672k 2023: €750k 2024: €273k
2018 → 2025
Total assets
€2.46M▼ 3.4%
2024 · €2.55M
2018: €3.80M 2019: €3.55M 2020: €3.37M 2021: €3.29M 2022: €3.07M 2023: €2.92M 2024: €2.55M
2018 → 2025
Net result
€-320k▲ 20.9%
2024 · €-404k
2018: €-505k 2019: €-418k 2020: €-453k 2021: €-396k 2022: €-554k 2023: €-505k 2024: €-404k
2018 → 2025
Working capital
€-2.37M▼ 6.8%
2024 · €-2.22M
2018: €-2.18M 2019: €-2.63M 2020: €-2.91M 2021: €-3.27M 2022: €-3.64M 2023: €-1.97M 2024: €-2.22M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€-56k-€-672k▼ 1,103%€750k€273k▼ 63.6%€-119k
Operating result€-409k-€-550k▼ 34.6%€-499k▲ 9.2%€-428k▲ 14.3%€-342k▲ 20.2%
Net result€-396k-€-554k▼ 39.8%€-505k▲ 8.9%€-404k▲ 19.9%€-320k▲ 20.9%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-600k€-400k€-200k€0Operating result 2021: €-409k€-409kNet result 2021: €-396k€-396kOperating result 2022: €-550k€-550kNet result 2022: €-554k€-554kOperating result 2023: €-499k€-499kNet result 2023: €-505k€-505kOperating result 2024: €-428k€-428kNet result 2024: €-404k€-404kOperating result 2025: €-342k€-342kNet result 2025: €-320k€-320k20212022202320242025€-600k€-400k€-200k€0Operating result 2023: €-499k€-499kNet result 2023: €-505k€-505kOperating result 2024: €-428k€-428kNet result 2024: €-404k€-404kOperating result 2025: €-342k€-342kNet result 2025: €-320k€-320k202320242025
The operating result stays negative: a loss of €342k in 2025 against €428k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.46M
Fixed assets €2.25M ▼ 9.7%
Current assets €215k ▲ 252%
Key figures and ratios
2025 value · change against 2024
EBITDA
€-76k
2024 · €-167k
Cash flow
€-54k
2024 · €-143k
Solvency
-4.8%
2024 · 10.7%
Current ratio
0.08
2024 · 0.03
Debt to equity
-21.62
2024 · 8.34
ROA
-13.0%
2024 · -15.9%
Interest coverage
-1.52
2024 · -3.44
Debt
€2.58M
2024 · €2.28M
Debt ≤ 1 year
€2.58M
2024 · €2.28M
Income taxes
€958
2024 · €674
Staff costs
€182k
2024 · €204k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet Code20242025
Assets
Total assets20/58€2.55M€2.46M
Fixed assets21/28€2.49M€2.25M
Intangible fixed assets21€2.49M€2.25M
Tangible fixed assets22/27€3k€2k
Plant, machinery and equipment23€903-
Other tangible fixed assets26€2k€2k
Current assets29/58€61k€215k
Amounts receivable within one year40/41€40k€196k
Trade receivables40€11k€196k
Other amounts receivable41€28k€69
Cash at bank and in hand54/58€17k€17k
Deferred charges and accrued income490/1€4k€2k
Equity and liabilities
Total equity and liabilities10/49€2.55M€2.46M
Equity10/15€273k€-119k
Contributions10/11€2.46M€2.46M=
Reserves13€30k€30k=
Distributable reserves133€30k€30k=
Profit (loss) carried forward14€-2.85M€-3.17M
Investment grants15€630k€557k
Amounts payable17/49€2.28M€2.58M
Amounts payable within one year42/48€2.28M€2.58M
Trade debts44€138k€179k
Suppliers440/4€138k€179k
Taxes, remuneration and social security45€30k€14k
Taxes450/3€3k€7k
Remuneration and social security454/9€28k€6k
Other amounts payable47/48€2.11M€2.39M
Income statement Code20242025
Remuneration, social security and pensions62€204k€182k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€261k€266k
Other operating charges640/8€1k€1k
Gross operating margin9900€39k€107k
Operating profit (loss)9901€-428k€-342k
Financial income75/76B€73k€73k=
Recurring financial income75€73k€73k=
Financial charges65/66B€48k€50k
Recurring financial charges65€48k€50k
Profit (loss) for the period before taxes9903€-404k€-319k
Income taxes67/77€674€958
Profit (loss) for the period9904€-404k€-320k
Profit (loss) for the period to be appropriated9905€-404k€-320k
Appropriation of the result
Profit (loss) to be appropriated9906€-2.85M€-3.17M
Profit (loss) brought forward from the previous period14P€-2.44M€-2.85M
Social balance
Average headcount (FTE)90872.01.8

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
25-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 25 days late
2025
29-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 29 days late
2024
29-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
31-12
Financial Equity above €500kEq €750k
Equity rises from €-672k to €750k.
30-06
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Weakest financial yearnet €-554k
Net result drops to €-554k, the lowest in the series; recovery starts the following year.
15-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
22-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
21-09
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 52 days late
2019
31-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
20-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
16-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
11 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2005
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Henri Farmanstraat 259000 Gent
Ground area
4.6 ha
Building footprint
286 m²
Volume, LiDAR
1,011 m³
Parcel 44812P0639/00G020, Flanders · tallest building 4.7 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Emulco Laboratories
Henri Farmanstraat 25, 9000 GentNACE 7420301
since 20052.148.657.886
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44812P0639/00G020 Flanders 4.6 ha 1 · 286 m² 4.7 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2022 to 2024 · 4 entries · 3,966 EUR awarded · 3,966 EUR paid
Year Entries awardedpaid
2024 1 36 EUR0 EUR
2023 2 3,898 EUR3,934 EUR
2022 1 32 EUR32 EUR
Schemes
Vlaams opleidingsverlof (VOV)
1 entry · 3,898 EUR · 3,898 EUR paid · Departement Werk en Sociale Economie
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
3 entries · 68 EUR · 68 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 537 companies in sector 46120 we hold annual accounts for 303. 209 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded10-06-2005
Fiscal year end31-12
Activities, NACEBEL 2025
46120Wholesale trade
46851Wholesale of industrial chemicals
71121Engineering and related technical consultancy, excluding land surveyors
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

Contact details

2 entries
E-mail:JEAN.VANHOEBOST@EMULCO-EUROPE.COM
Establishment Gent 2.148.657.886
Phone:0475/47 12 19
Establishment Gent 2.148.657.886